Clinical value of serum markers in patients with breast cancer and breast cancer after operation of stage III and IV
Objective To investigate the clinical value of serum markers in patients with breast cancer and breast cancer after operation of stage III and IV. Methods 200 cases of patients with breast disease were admitted to our hospital from February 2015 to February 2017, according to the pathological type of benign breast tumor group, which group of 50 cases, 100 cases of breast cancer group (60 cases of stage I and II, III - IV 40 cases), 50 cases of recurrence in postoperative contrast serum marker object detection. Results Breast cancer group, postoperative breast cancer recurrence in group CEA, CA15-3, CA125 positive rate was significantly higher than that of benign breast cancer, breast cancer stage III and IV group positive rates were higher than those of stage I and II group, the positive rate of combined detection was significantly higher than that of single detection (P<0.05). Conclusion The combined detection of CEA, CA15-3 and CA125 is superior to single detection for the cases of breast cancer and breast cancer after stage III and IV, which can provide an accurate reference for clinical diagnosis and prognosis evaluation.
stage III - IV breast cancerpostoperative progressionrecurrenceserum markersvalue
NETL
NSTL
万方数据
